Search

everythingexperts & clinicslearnresearchcommunity

for

Search:↓

Upadacitinib effectively treats severe alopecia areata and is safe.

Tofacitinib is effective and safe for treating severe alopecia areata.

Ritlecitinib effectively regrows hair in severe alopecia areata and is well tolerated.

Abrocitinib effectively treated severe atopic dermatitis and mild alopecia areata in a 12-year-old boy after dupilumab failed.

Comprehensive screening for infections is crucial before starting JAK inhibitors in alopecia areata patients.

Tofacitinib helped regrow hair in most patients with severe hair loss.

A woman had temporary hair loss due to stress from a spinal cord injury.

Methotrexate treatment for rheumatoid arthritis has a serious infection rate of about two per 100 patient-years.

The document concludes that Syndromes of Severe Insulin Resistance are rare disorders with limited treatment options.

Distinct miRNA signatures could help diagnose and treat severe Alopecia Areata.

Baricitinib is effective and safe for treating severe alopecia areata.

Researchers found a specific immune receptor in patients that causes severe skin reactions to a drug.

Dupilumab may cause hair loss in some patients with severe atopic dermatitis.

Non-invasive imaging helped diagnose a woman's severe hormone imbalance and diabetes, and medication successfully treated her condition.

Topical anaesthesia reduces injection pain better than a vibrating device.

Injecting 2 ml of TEEV every 4 weeks is better because it has the same benefits but fewer side effects.

Mice lacking the PPARγ gene in their fat cells had almost no fat tissue, severe metabolic problems, and abnormal development of other fat-related tissues.

Dermal papillae cells, important for hair growth, come from multiple cell lines and can be formed by skin cells, regardless of their origin or hair cycle phase. These cells rarely divide, but their ability to shape tissue may contribute to their efficiency in inducing hair growth.

About half the patients treated with capecitabine and docetaxel developed severe hand-foot syndrome.

FOXN1 gene variants cause low T cells and immune issues from birth.

Long COVID causes various long-term health issues and needs better awareness and treatment.

The document concludes that various treatments for skin conditions are effective, but some require further research, and certain factors like gender and lifestyle can influence disease outcomes.

Hair loss doesn't affect COVID-19 severity.

Tofacitinib may be safe for COVID-19 patients with alopecia without worsening symptoms, based on two cases.

The random forest model effectively helps diagnose COVID-19 using key factors like age and symptoms.

Both ruxolitinib and tofacitinib are effective and safe for treating severe alopecia areata, but relapses are common.

Zinc supplements may be needed to treat hair loss in hypothyroidism.

People with PCNT mutations often develop severe insulin resistance and early-onset diabetes during childhood or adolescence.

Minoxidil lowers blood pressure effectively but may cause unwanted hair growth and other side effects.

Anti-androgens, like finasteride, dutasteride, and spironolactone, may lessen the severity of COVID-19 in men, leading to fewer ICU admissions.